Related Experiment Video
Updated: Mar 7, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Heart failure guidelines: What's new?
Lampros Papadimitriou1, Carine E Hamo1, Javed Butler1
1From the Division of Cardiology, Department of Medicine, Stony Brook University, Stony Brook, NY, USA.
Abstract:
Heart Failure is a global epidemic, affecting approximately 5 million adults in the U.S.A. The cornerstone of contemporary pharmacological therapy targets the over activated renin-angiotensin-aldosterone and sympathetic autonomic systems. The 2016 focused pharmacologic update on the current Heart Failure Guidelines introduces the use of two newly approved regimens valsartan/sacubitril and ivabradine. Over the last two decades, guideline directed medical therapy has accomplished significant improvement in survival rates among heart failure patients; however these novel compounds were reported to exert additional mortality and morbidity benefits, in heart failure subpopulations with reduced ejection fraction.
More Related Videos
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure I: Introduction
Pathophysiology of Heart Failure

